Comparison of the pharmacokinetics of (68)Ga-DOTATOC and [(18)F]FDG in patients with metastatic neuroendocrine tumours scheduled for (90)Y-DOTATOC therapy. - Koukouraki,S.; Strauss,L.G.; Georgoulias,V.; Eisenhut,M.; Haberkorn,U.; Dimitrakopoulou-Strauss,A. (Eur J Nucl Med Mol Imaging, 2006)